A centralised electronic Multidrug-Resistant Tuberculosis Advisory Service: The first 2 years

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 7, 2012, Pages 950-954

  Jordan, T S ^a   Cullen, D ^b   Davies, Peter D O ^b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Electronic; Multidrug resistance; Tuberculosis; Website

Indexed keywords

AMIKACIN; ETHAMBUTOL; MOXIFLOXACIN; PYRAZINAMIDE; STREPTOMYCIN;

ACCESS TO INFORMATION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DATA PROCESSING; DRUG CHOICE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH SERVICE; HEARING LOSS; HUMAN; INFANT; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; SCHOOL CHILD; TINNITUS; UNITED KINGDOM; WEB BROWSER;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CONSULTANTS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INFANT; MALE; MIDDLE AGED; PHYSICIANS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84862193012     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0411     Document Type: Article

References (16)

1. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-432.
2. Kruijshaar M E, Watson J M, Drobniewski F, et al. Increasing anti-tuberculosis drug resistance in the United Kingdom: analysis of national surveillance data. BMJ 2008; 336: 1231-1234. (Pubitemid 351809318)
3. Health Protection Agency. Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK 2010. London, UK: HPA, 2010.
4. World Heath Organization. Global tuberculosis control. WHO report 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010.
5. Falzon D, Jaramillo E, Schunemann H J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
6. Coninx R, Mathieu C, Debacker M, et al. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet 1999; 353: 969-973. (Pubitemid 29132606)
7. Abubakar I, Moore J, Drobniewski F, et al. Extensively drug-resistant tuberculosis in the UK: 1995-2007. Thorax 2009; 64: 512-515.
8. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: Royal College of Physicians, 2006.
9. Kerbiriou L, Moore-Gillon J. Managing multidrug-resistant tuberculosis in the UK. Thorax 2006; 61: ii48.
10. Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J 2009; 33: 1085-1094.
11. Leimane V, Riekstina V, Holtz T H, et al. Clinical outcome of individualised treatment of multi-drug resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005; 365: 318-326. (Pubitemid 40139109)
12. Marra F, Marra C A, Moadebi S, et al. Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest 2005; 128: 1406-1413. (Pubitemid 41324425)
13. Ziganshina L E, Vizel A A, Squire S B. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 2005; (3): CD004795.
14. World Health Organization. Management of MDR-TB: a field guide. A companion document to guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/ TB/2008.402a. Geneva, Switzerland: WHO, 2009.
15. Broekmans J, Migliori G B, Rieder H L, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-775.
16. Migliori G B, Sotgiu G, Blasi F, et al. Towards the development of EU/EEA Standards for TB Care (ESTC). Eur Respir J 2011; 38: 493-495.